Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Akeso, Alteogen, Alvotech, Biocon, Celltrion, Daiichi Sankyo, Eisai, Esperioin, Henlius, Innovent, Ipsen, Nuvation, Polyrizon, Verrica.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Techsomed, Tempus.

Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Alvotech, Ars, Celltrion, Esperion, Fuji, Henlius, Idorsia, Incyte, Innovent, Ionis, Ipsen, Johnson & Johnson, Kalvista, Merck, NS, Nuvation Bio, Polyrizon, Organon, Otsuka, Roche, Torii, Verrica.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Kelyniam, Medtronic.

Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Astrazeneca, Biogen, Curatis, Deciphera, J&D, Minovia, Replimune.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Boston Scientific, Brainlab, Ruthless Spine.

Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Alteogen, Biocon, Eisai, Rgenta.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Amber Impants, Roche.

Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Akeso, Corbus.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Avita Medical, Biocartis, Body Vision Medical, Penumbra, Womed.